PL2768479T3 - Zaróbki do kompozycji terapeutycznych zawierających nikotynę - Google Patents
Zaróbki do kompozycji terapeutycznych zawierających nikotynęInfo
- Publication number
- PL2768479T3 PL2768479T3 PL12783465T PL12783465T PL2768479T3 PL 2768479 T3 PL2768479 T3 PL 2768479T3 PL 12783465 T PL12783465 T PL 12783465T PL 12783465 T PL12783465 T PL 12783465T PL 2768479 T3 PL2768479 T3 PL 2768479T3
- Authority
- PL
- Poland
- Prior art keywords
- nicotine
- excipients
- therapeutic compositions
- containing therapeutic
- compositions
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960002715 nicotine Drugs 0.000 title 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/278,877 US9907748B2 (en) | 2011-10-21 | 2011-10-21 | Excipients for nicotine-containing therapeutic compositions |
| PCT/US2012/061023 WO2013059592A1 (en) | 2011-10-21 | 2012-10-19 | Excipients for nicotine-containing therapeutic compositions |
| EP12783465.3A EP2768479B1 (en) | 2011-10-21 | 2012-10-19 | Excipients for nicotine-containing therapeutic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2768479T3 true PL2768479T3 (pl) | 2020-12-28 |
Family
ID=47144140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20174169.1T PL3744313T3 (pl) | 2011-10-21 | 2012-10-19 | Zaróbki do kompozycji terapeutycznych zawierających nikotynę |
| PL12783465T PL2768479T3 (pl) | 2011-10-21 | 2012-10-19 | Zaróbki do kompozycji terapeutycznych zawierających nikotynę |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20174169.1T PL3744313T3 (pl) | 2011-10-21 | 2012-10-19 | Zaróbki do kompozycji terapeutycznych zawierających nikotynę |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9907748B2 (pl) |
| EP (3) | EP2768479B1 (pl) |
| JP (1) | JP6228544B2 (pl) |
| CN (1) | CN104114151A (pl) |
| DK (2) | DK2768479T3 (pl) |
| ES (1) | ES2811113T3 (pl) |
| FI (1) | FI3744313T3 (pl) |
| HU (1) | HUE051459T2 (pl) |
| PL (2) | PL3744313T3 (pl) |
| WO (1) | WO2013059592A1 (pl) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9763928B2 (en) * | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| PL2925395T3 (pl) | 2012-11-28 | 2019-08-30 | Fontem Holdings 1 B.V. | Urządzenie wytwarzające aerozol kondensacyjny z ciekłej formulacji |
| CA3208137A1 (en) | 2013-05-06 | 2014-11-13 | Juul Labs, Inc. | Nicotine salt formulations for aerosol devices and methods thereof |
| WO2015042412A1 (en) | 2013-09-20 | 2015-03-26 | E-Nicotine Technology. Inc. | Devices and methods for modifying delivery devices |
| US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
| CN119606056A (zh) | 2013-12-05 | 2025-03-14 | 尤尔实验室有限公司 | 用于气雾剂装置的尼古丁液体制剂及其方法 |
| US11019840B2 (en) | 2014-07-02 | 2021-06-01 | R.J. Reynolds Tobacco Company | Oral pouch products |
| US10959456B2 (en) | 2014-09-12 | 2021-03-30 | R.J. Reynolds Tobacco Company | Nonwoven pouch comprising heat sealable binder fiber |
| US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
| US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
| US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US20170071248A1 (en) | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
| US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
| ES2965015T3 (es) * | 2016-02-29 | 2024-04-10 | Emplicure Ab | Dispositivos de evaporación e inhalación de principios activos |
| WO2018122095A1 (en) | 2016-12-30 | 2018-07-05 | Philip Morris Products S.A. | Nicotine and cellulose containing sheet |
| US11297876B2 (en) | 2017-05-17 | 2022-04-12 | Rai Strategic Holdings, Inc. | Aerosol delivery device |
| SE541358C2 (en) * | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
| EP3641731A1 (en) * | 2017-06-23 | 2020-04-29 | Fertin Pharma A/S | Nicotine pouch |
| PL3641726T3 (pl) * | 2017-06-23 | 2026-02-23 | Nordiccan A/S | Woreczek z kannabinoidami |
| US11166935B2 (en) | 2017-06-23 | 2021-11-09 | Nordiccan A/S | Cannabinoid pouch |
| PH12021553026A1 (en) | 2019-07-05 | 2023-08-23 | Swedish Match North Europe Ab | An oral pouched nicotine product including a filling material comprising nicotine-containing particles |
| US12213510B2 (en) | 2019-09-11 | 2025-02-04 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
| US12342847B2 (en) | 2019-09-11 | 2025-07-01 | Nicoventures Trading Limited | Oral product with cellulosic flavor stabilizer |
| SE1951054A1 (en) * | 2019-09-18 | 2021-03-19 | Enorama Pharma Ab | Nicotine pouch |
| EP4663029A1 (en) | 2019-10-31 | 2025-12-17 | Nicoventures Trading Limited | Oral product and method of manufacture |
| HRP20231531T1 (hr) | 2019-11-20 | 2024-03-01 | Swedish Match North Europe Ab | Nikotinski proizvod u vrećici za oralnu upotrebu koji uključuje materijal za punjenje koji sadržava čestice nikotina |
| US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
| US12599160B2 (en) | 2019-12-09 | 2026-04-14 | Nicoventures Trading Limited | Lipid-containing oral composition |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| US12491250B2 (en) | 2019-12-09 | 2025-12-09 | Nicoventures Trading Limited | Oral composition with nanocrystalline cellulose |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| JP2023505351A (ja) | 2019-12-09 | 2023-02-08 | ニコベンチャーズ トレーディング リミテッド | 口腔用組成物のための薬剤 |
| US12550928B2 (en) | 2019-12-09 | 2026-02-17 | Nicoventures Trading Limited | Liquid oral composition |
| US12520867B2 (en) | 2019-12-09 | 2026-01-13 | Nicoventures Trading Limited | Buffered oral compositions |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| CA3159297A1 (en) * | 2019-12-09 | 2021-06-17 | Jr. Darrell Eugene Holton | Oral products with controlled release |
| US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
| US12137723B2 (en) | 2019-12-09 | 2024-11-12 | Nicoventures Trading Limited | Oral products with active ingredient combinations |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US12691059B2 (en) | 2019-12-09 | 2026-07-28 | Nicoventures Trading Limited | Oral composition with polymeric component |
| US12171872B2 (en) | 2019-12-09 | 2024-12-24 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
| US12151023B2 (en) | 2019-12-09 | 2024-11-26 | Nicoventures Trading Limited | Oral composition with beet material |
| US11969502B2 (en) * | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| EP4072516A1 (en) | 2019-12-09 | 2022-10-19 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
| US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
| SE544672C2 (en) * | 2020-05-07 | 2022-10-11 | Liw Innovation Ab | New compositions for oral or nasal use |
| JP2023530239A (ja) | 2020-06-08 | 2023-07-14 | ニコベンチャーズ トレーディング リミテッド | 発泡性口腔組成物 |
| US12551477B2 (en) * | 2020-09-22 | 2026-02-17 | Fertin Pharma A/S | Oral antagonist compositions for nicotine burning relief |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
| US11382861B1 (en) * | 2020-12-17 | 2022-07-12 | Nirajkumar Karneshbhai Patel | Nicotine pouch |
| US12382982B2 (en) | 2021-06-25 | 2025-08-12 | Nicoventures Trading Limited | Oral products and method of manufacture |
| CN119789793A (zh) | 2021-07-30 | 2025-04-08 | 尼科凡图尔斯贸易有限公司 | 包含微晶纤维素的气溶胶发生基材 |
| JP2024536230A (ja) | 2021-09-30 | 2024-10-04 | ニコベンチャーズ トレーディング リミテッド | 塩基性アミン及びイオン対形成剤を含む口腔用製品 |
| EP4408184A1 (en) | 2021-09-30 | 2024-08-07 | Nicoventures Trading Limited | Oral gum composition |
| US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
Family Cites Families (136)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2033909A (en) | 1934-12-19 | 1936-03-17 | Niacet Chemicals Corp | Manufacture of calcium levulinate |
| US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
| US3877468A (en) | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
| US3845217A (en) | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
| US4284809A (en) | 1979-04-02 | 1981-08-18 | The Upjohn Company | 13,14-Didehydro-inter-oxa-19-oxo-PGF1 compounds |
| GB8301659D0 (en) | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| US4655231A (en) | 1984-01-09 | 1987-04-07 | Advanced Tobacco Products, Inc. | Snuff and preparation thereof |
| US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
| US4800903A (en) | 1985-05-24 | 1989-01-31 | Ray Jon P | Nicotine dispenser with polymeric reservoir of nicotine |
| GB8615676D0 (en) | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
| US4830028A (en) | 1987-02-10 | 1989-05-16 | R. J. Reynolds Tobacco Company | Salts provided from nicotine and organic acid as cigarette additives |
| IL86170A (en) | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
| US5834011A (en) | 1988-02-19 | 1998-11-10 | The Regents Of The University Of California | Method for aiding in the reduction of incidence of tobacco smoking |
| US5004610A (en) | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| US5154927A (en) | 1989-01-19 | 1992-10-13 | Wm. Wrigley Jr. Company | Gum composition containing dispersed porous beads containing active chewing gum ingredients and method |
| US5525351A (en) | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
| US5512306A (en) | 1992-06-19 | 1996-04-30 | Pharmica Ab | Smoking substitute |
| SE8904295D0 (sv) | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Smoking substitute |
| US5167242A (en) | 1990-06-08 | 1992-12-01 | Kabi Pharmacia Aktiebolaq | Nicotine-impermeable container and method of fabricating the same |
| US5147654A (en) | 1990-07-23 | 1992-09-15 | Alza Corporation | Oral osmotic device for delivering nicotine |
| US5110605A (en) | 1990-08-21 | 1992-05-05 | Oramed, Inc. | Calcium polycarbophil-alginate controlled release composition and method |
| JPH05255066A (ja) | 1991-04-25 | 1993-10-05 | Takeda Chem Ind Ltd | 製剤用組成物、製剤およびそれらの製造方法 |
| GB9200047D0 (en) | 1992-01-03 | 1992-02-26 | Univ Alberta | Nicotine-containing nasal spray |
| US6024097A (en) | 1992-02-20 | 2000-02-15 | J Mom Trust | Product for assisting a smoker in giving up the habit |
| US6098632A (en) | 1992-11-25 | 2000-08-08 | Pharmacia & Upjohn Ab | Nicotine-impermeable container and method of fabricating the same |
| US6602892B1 (en) | 1993-06-10 | 2003-08-05 | David P. L. Sachs | Methods for nicotine replacement dosage determination |
| DE69422925T2 (de) | 1993-07-09 | 2000-08-17 | Cygnus, Inc. | Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten |
| US5549906A (en) | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
| US5362496A (en) | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
| SE9303574D0 (sv) | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
| IT1274034B (it) | 1994-07-26 | 1997-07-14 | Applied Pharma Res | Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione |
| US5723477A (en) | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
| US5604231A (en) | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| US5583140A (en) | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
| US5811126A (en) | 1995-10-02 | 1998-09-22 | Euro-Celtique, S.A. | Controlled release matrix for pharmaceuticals |
| WO1997038679A2 (en) | 1996-04-16 | 1997-10-23 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
| US6166048A (en) | 1999-04-20 | 2000-12-26 | Targacept, Inc. | Pharmaceutical compositions for inhibition of cytokine production and secretion |
| GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
| DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| US5811442A (en) | 1997-02-21 | 1998-09-22 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| US7214686B2 (en) | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
| US20030176467A1 (en) | 1997-09-25 | 2003-09-18 | Sven Andersson | Nicotine compositions |
| US6268386B1 (en) | 1998-06-25 | 2001-07-31 | Marshall Anlauf Thompson | Nicotine beverage |
| US6234169B1 (en) | 1998-08-14 | 2001-05-22 | Arthur Slutsky | Inhaler |
| US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
| US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
| US20020098264A1 (en) | 1998-11-27 | 2002-07-25 | Cherukuri Subraman R. | Medicated chewing gum delivery system for nicotine |
| US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| SE9803986D0 (sv) | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
| GB9826192D0 (en) | 1998-12-01 | 1999-01-20 | Controlled Theraputics Scotlan | Oral transmucosal delivery |
| US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
| AU3470600A (en) | 1999-01-14 | 2000-08-01 | David Houze | Compositions and methods for drug delivery |
| US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6090401A (en) | 1999-03-31 | 2000-07-18 | Mcneil-Ppc, Inc. | Stable foam composition |
| US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
| US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
| US6426090B1 (en) | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
| US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
| US6248760B1 (en) | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
| US20010016593A1 (en) | 1999-04-14 | 2001-08-23 | Wilhelmsen Paul C. | Element giving rapid release of nicotine for transmucosal administration |
| US6583160B2 (en) | 1999-04-14 | 2003-06-24 | Steve Smith | Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| US6319510B1 (en) | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
| GB9911037D0 (en) | 1999-05-13 | 1999-07-14 | Micap Limited | Nicotine delivery service |
| US6799576B2 (en) | 1999-07-16 | 2004-10-05 | Aradigm Corporation | System for effecting smoking cessation |
| US8256433B2 (en) | 1999-07-16 | 2012-09-04 | Aradigm Corporation | Systems and methods for effecting cessation of tobacco use |
| JP4999245B2 (ja) | 1999-07-16 | 2012-08-15 | アラディグム コーポレイション | 禁煙を達成するためのシステム |
| US20080138398A1 (en) | 1999-07-16 | 2008-06-12 | Aradigm Corporation | Dual release nicotine formulations, and systems and methods for their use |
| US6322828B1 (en) | 1999-09-13 | 2001-11-27 | Deseret Laboratories, Inc. | Process for manufacturing a pharmaceutical chewing gum |
| US6660754B1 (en) | 2000-02-15 | 2003-12-09 | Smithkline Beecham Corporation | Method for reducing or eliminating smoking |
| US7115297B2 (en) | 2000-02-22 | 2006-10-03 | Suzanne Jaffe Stillman | Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
| US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| US6596740B2 (en) | 2000-10-24 | 2003-07-22 | Richard L. Jones | Nicotine mucosal spray |
| NZ528167A (en) | 2001-03-26 | 2005-04-29 | Smithkline Beecham Corp | Nicotine-containing oral dosage form |
| FR2823974B1 (fr) | 2001-04-25 | 2004-10-15 | Pf Medicament | Pastille medicamenteuse a liberation lente du principe actif |
| SE0102197D0 (sv) | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| US6585997B2 (en) | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| US7208186B2 (en) | 2001-09-18 | 2007-04-24 | Spi Pharma, Inc. | Chewing gum formulation and method of making the same |
| CN1602193A (zh) | 2001-12-10 | 2005-03-30 | 约瑟夫·罗伯特·奈特 | 用烟碱处理的饮料 |
| SE0104388D0 (sv) | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| US20030159702A1 (en) | 2002-01-21 | 2003-08-28 | Lindell Katarina E.A. | Formulation and use manufacture thereof |
| CA2474190A1 (en) | 2002-02-07 | 2003-08-14 | Pharmacia Corporation | Pharmaceutical dosage form for mucosal delivery |
| MXPA04007083A (es) | 2002-02-20 | 2004-10-29 | Upjohn Co | Compuestos azabiciclicos para el tratamiento de enfermedades. |
| US7105173B1 (en) | 2002-03-21 | 2006-09-12 | Rolling Kenneth J | Nicotine replacement applique |
| US20040101543A1 (en) | 2002-03-22 | 2004-05-27 | John Liu | Nicotine-containing oral dosage form |
| SE0201669D0 (sv) | 2002-06-03 | 2002-06-03 | Pharmacia Ab | New formulation and use thereof |
| US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
| US8216609B2 (en) | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
| US7135484B2 (en) | 2002-08-14 | 2006-11-14 | Abbott Laboratories | Azabicyclic compounds are central nervous system active agents |
| US20040052851A1 (en) | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
| EP1542542B2 (en) | 2002-09-24 | 2013-09-04 | Gumlink A/S | Biodegradable chewing gum comprising at least one high molecular weight biodegradable polymer |
| AU2002342580B2 (en) | 2002-09-24 | 2008-05-15 | Gumlink A/S | Degradable chewing gum polymer |
| CN1668206A (zh) | 2002-09-24 | 2005-09-14 | 古木林科有限公司 | 改进口香糖成分释放的口香糖 |
| EP1542541B2 (en) | 2002-09-24 | 2016-09-07 | Gumlink A/S | Low moisture chewing gum |
| EP1578422B1 (en) | 2002-12-20 | 2007-04-11 | NicoNovum AB | A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material |
| JP5283334B2 (ja) * | 2003-01-24 | 2013-09-04 | マグル ホールディング エービー | 経粘膜伝達用組成物材料 |
| EP1449525A1 (en) | 2003-02-20 | 2004-08-25 | Cross Chem Llc | chewing gum in the form of multi-layer tablets |
| US20040182403A1 (en) | 2003-02-28 | 2004-09-23 | Sven-Borje Andersson | Container comprising nicotine and the use and manufacture thereof |
| CN100381083C (zh) | 2003-04-29 | 2008-04-16 | 韩力 | 一种非可燃性电子喷雾香烟 |
| PT2446881E (pt) | 2003-07-24 | 2014-06-11 | Glaxosmithkline Llc | Películas de dissolução oral |
| GB0320854D0 (en) | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
| DK1663168T3 (da) | 2003-09-08 | 2009-06-08 | Mcneil Ab | Nikotinformuleringer og anvendelse deraf |
| US20050123502A1 (en) | 2003-10-07 | 2005-06-09 | Chan Shing Y. | Nicotine containing oral compositions |
| WO2005053691A2 (en) | 2003-12-02 | 2005-06-16 | Fertin Pharma A/S | Nicotine delivery product and method for producing it |
| WO2006004646A1 (en) | 2004-06-28 | 2006-01-12 | Nektar Therapeutics | Aerosol formulation comprising nicotine salt |
| EP1817014B1 (en) | 2004-11-30 | 2012-08-22 | Fertin Pharma A/S | Method of providing fast relief to a user of a nicotine chewing gum |
| US20090023819A1 (en) | 2005-03-22 | 2009-01-22 | Anders Axelsson | Use of an Artificial Sweetener to Enhance Absorption of Nicotine |
| US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| EP1890698B1 (en) | 2005-06-01 | 2009-11-18 | Fertin Pharma A/S | A method of manufacturing a nicotine delivery product |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| AU2007224586A1 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Stable lozenge compositions providing rapid release of nicotine |
| US20070269492A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US20070269386A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
| KR20090055606A (ko) | 2006-09-27 | 2009-06-02 | 니코노범 에이비 | 지향성 용도 |
| BRPI0719428A2 (pt) | 2006-12-01 | 2014-02-25 | Cima Labs Inc | Forma de dosagem transmucosal oral sólida, método para tratar dependência de nicotina em um receptor que deseja tal tratamento, sistema de distribuição de nicotina transmucosal oral, e, método de substituíção de nicotina. |
| US20080286340A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
| US20080286341A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
| US20080292683A1 (en) | 2007-05-24 | 2008-11-27 | Monosolrx, Llc. | Film shreds and delivery system incorporating same |
| US20090004248A1 (en) | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
| CA2699806A1 (en) * | 2007-09-18 | 2009-03-26 | Niconovum Ab | Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
| US20090081291A1 (en) | 2007-09-26 | 2009-03-26 | Gin Jerry B | Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User |
| KR20100095581A (ko) | 2007-12-11 | 2010-08-31 | 노파르티스 아게 | 다-영역 필름 |
| EP2268639A2 (en) | 2008-05-22 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
| US20100018539A1 (en) | 2008-07-28 | 2010-01-28 | Paul Andrew Brinkley | Smokeless tobacco products and processes |
| US8833378B2 (en) | 2008-09-17 | 2014-09-16 | Niconovum Ab | Process for preparing snuff composition |
| PT2361081T (pt) | 2008-10-14 | 2016-09-05 | Mcneil Ab | Forma de dosagem intra-oral multiporção e seu uso |
| PL2405942T3 (pl) | 2009-03-13 | 2018-04-30 | Excellent Tech Products I Sverige Ab | Produkt do podawania doustnego |
| EP2233134A1 (en) | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
| US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
| US20100256197A1 (en) | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
| KR101138851B1 (ko) | 2009-04-27 | 2012-05-09 | 김만규 | 금연 껌 조성물 및 그를 이용한 금연 껌 제조방법 |
| US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
-
2011
- 2011-10-21 US US13/278,877 patent/US9907748B2/en active Active
-
2012
- 2012-10-19 FI FIEP20174169.1T patent/FI3744313T3/fi active
- 2012-10-19 EP EP12783465.3A patent/EP2768479B1/en not_active Revoked
- 2012-10-19 PL PL20174169.1T patent/PL3744313T3/pl unknown
- 2012-10-19 WO PCT/US2012/061023 patent/WO2013059592A1/en not_active Ceased
- 2012-10-19 EP EP20174169.1A patent/EP3744313B1/en not_active Revoked
- 2012-10-19 PL PL12783465T patent/PL2768479T3/pl unknown
- 2012-10-19 EP EP24216877.1A patent/EP4512484A3/en active Pending
- 2012-10-19 JP JP2014537286A patent/JP6228544B2/ja active Active
- 2012-10-19 DK DK12783465.3T patent/DK2768479T3/da active
- 2012-10-19 DK DK20174169.1T patent/DK3744313T3/da active
- 2012-10-19 ES ES12783465T patent/ES2811113T3/es active Active
- 2012-10-19 HU HUE12783465A patent/HUE051459T2/hu unknown
- 2012-10-19 CN CN201280060724.4A patent/CN104114151A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI3744313T3 (fi) | 2025-02-16 |
| PL3744313T3 (pl) | 2025-05-12 |
| JP6228544B2 (ja) | 2017-11-08 |
| WO2013059592A1 (en) | 2013-04-25 |
| EP4512484A2 (en) | 2025-02-26 |
| CN104114151A (zh) | 2014-10-22 |
| ES2811113T3 (es) | 2021-03-10 |
| JP2014530871A (ja) | 2014-11-20 |
| US20130098377A1 (en) | 2013-04-25 |
| EP3744313B1 (en) | 2024-12-04 |
| EP3744313A1 (en) | 2020-12-02 |
| DK3744313T3 (da) | 2025-03-03 |
| HUE051459T2 (hu) | 2021-03-01 |
| DK2768479T3 (da) | 2020-08-10 |
| EP2768479B1 (en) | 2020-07-15 |
| EP2768479A1 (en) | 2014-08-27 |
| US9907748B2 (en) | 2018-03-06 |
| EP4512484A3 (en) | 2025-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3744313T3 (pl) | Zaróbki do kompozycji terapeutycznych zawierających nikotynę | |
| IL230010B (en) | Inhalable pharmaceutical ingredients | |
| ZA201407726B (en) | Pharmaceutical compositions for combination therapy | |
| GB201113662D0 (en) | Pharmaceutical compositions | |
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| AP3656A (en) | Pharmaceutical compositions | |
| ZA201308208B (en) | Pharmaceutical compositions | |
| SG11201400580VA (en) | Pharmaceutical composition for inhalation | |
| IL232305A0 (en) | pharmaceutical preparations | |
| IL231988A (en) | Oral solution | |
| PT2773348T (pt) | Composição farmacêutica de omeprazol | |
| IL236636A0 (en) | Difluorolactam formulations for ep4-mediated bone-related conditions and diseases | |
| LT2814473T (lt) | Farmacinės kompozicijos, skirtos derinių terapijai | |
| SG11201402226PA (en) | Therapeutic agent for arthrosis | |
| GB201118181D0 (en) | Pharmaceutical compositions | |
| EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL233236A0 (en) | Dosing regimen for preparations containing apolipoprotein | |
| GB201102913D0 (en) | Novel therapeutic | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| HUE043019T2 (hu) | Gyógyszerészeti készítmények kombinációs terápia céljára |